Find a Tender
planning
Official procurement procedure
Supply and Support of Complete Antibody Quantification Testing Systems
Medical consumables
Published value
£1,200,000
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS Blood and Transplant: "Supply and Support of Complete Antibody Quantification Testing Systems". Published status: planning. Published value: £1,200,000. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | NHS Blood and Transplant | Scope & Categories | Not published | Submission Window | planning No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | £1,200,000 |
Bidder Intelligence · Authority Profile: NHS Blood and Transplant
Market Analytics
Derived from OCDS awards & bid statistics
Published history for NHS Blood and Transplant. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
1.9Bids / Report
Supplier ConcentrationHigh Concentration
Carmelcrest LtdTop vendor: 66.6% of attributable valuePayment Terms
Check noticePublished terms
Coverage: 65 active published awards; 20 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Historical Awarded Suppliers With This Authority:
| Supplier Name | Historic Awards | Attributable GBP Value |
|---|---|---|
| Carmelcrest Ltd | 1 win | £1,098,370 |
| Jobtrain Limited | 2 wins | £186,954 |
| CRYOPDP | 1 win | £108,014 |
| Arctic Shores Limited | 1 win | £93,000 |
| Osteopaths For Industry Limited | 1 win | £60,000 |
Procedure terms
Contracting AuthorityNHS Blood and Transplant | Procedure methodNot published | Procurement categoryNot published |
Statusplanning | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published1 Apr 2025, 12:31 BST | Last source update1 Apr 2025, 12:31 BST | Recurring procurementNot published |
ClassificationMedical consumables | ||
Delivery area | ||
OCIDocds-h6vhtk-04fb3d | ||
What is being bought
Anti-D and Anti-c Antibody Quantification NHS Blood & Transplant (NHSBT) Red Cell Immunohaematology (RCI) function is seeking to engage with suppliers of red cell antibody quantification methods via an early market engagement exercise. Please note this is not the start of a procurement process; a separate contract notice will be published to cover this requirement. Prior to commencing the formal procurement process, NHSBT would like to consult the market to improve our knowledge of all current offers available, identify further opportunities and potential issues, as well as gauge market interest in the proposed service. This engagement will help shape NHSBT procurement strategy. The RCI laboratories in NHSBT provide a range of reference services to hospitals, focusing on ensuring safe and effective blood transfusions by diagnosing and managing complex issues related to red blood cells. Antibody (anti-D and anti-c) quantification is a vital component of RCI service, predominantly providing service to NHS hospitals. The test results play a crucial role in guiding the clinical management of alloimmunised ANC patients’ by predicting the risk of haemolytic disease of the foetus and newborn and triggering referral to an FMU specialist, In addition, quantification is used to assist in the laboratory differentiation of immune anti-D from passive anti-D Ig This specialised test conducted in 4 of the 7 RCI laboratories (namely Birmingham, Colindale, Liverpool and Newcastle). RCI processes approximately 10,000 tests annually. The test is vital for identifying levels of alloimmune and prophylactic anti-D, as well as alloimmune anti-c in obstetric and other referrals. NHSBT is seeking to engage with suppliers on the market who can provide Antibody Quantification. The requirement is likely to include the following: • Quantification of anti-D and anti-c (expressed in IU/mL). • Less than 24-hour TAT • Quality requirements (such as CE marked) As part of the early market engagement exercise, NHSBT would like to discuss our requirement with suppliers along with a time frame for supply.
What changed
From the official release history
- Published value updated to £1,200,000
1 Apr 2025, 12:31 BST - Status changed to planning
1 Apr 2025, 12:31 BST - Official notice release published
1 Apr 2025, 12:31 BST - Buyer information updated
1 Apr 2025, 12:31 BST
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedplanningPublished valueNot publishedThe source published no individual title or description for this lot.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Pipeline notice
1 Apr 2025, 12:31 BST - Procedure published
1 Apr 2025, 12:31 BST - engagement
21 May 2025, 23:59 BST · scheduledIt is our intention to hold the early market engagement exercise supplier meetings the week of 19th May 2025. The meetings will be held remotely. To enable us to finalise arrangements (e.g. send meeting details and agree time slots), interested organisations are required to send an expression of interest via email to coco.otiotio@nhsbt.nhs.uk by no later than 17:00 hrs (GMT) on Friday 2nd May. This should include a list of your requested attendees and a brief overview (or a website link) of the Goods / Services which might be of interest to us in relation to this requirement. Please include options, if available, for a managed service contract. There is no guarantee that a formal procurement process will be launched as a result of this early market engagement exercise, nor that any contract(s) will be placed. No remuneration or compensation etc will be paid to organisations who take part in this early market engagement exercise. Suppliers should take part in this process only on the basis that they fully understand and accept this position.
Commercial outcome and competition
AwardsNo award published |
ContractsNo contract published |
Bid statisticsNo aggregate bid statistics published |
Buyer and organisations in this procedure
NHS Blood and Transplant
Contracting authority GB-PPON-PDBY-6395-VWBPDocuments (1)
Official links; attachments are not copied
- 1 Apr 2025, 12:31 BST
Related procedures (0)
No related procedures published
Planning and rationale
Planning budgetNot published |
No-engagement rationaleNot published |
Procedure rationaleNot published |